Potentially effective therapy for human prion disease identified
Washington, April 4 (ANI): American researchers have for the first time identified a pair of drugs already approved for human use that effectively acts against prion disease.
Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet-incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.
The most well-known of these is Creutzfeldt-Jakob disease, which can be described as the naturally occurring human equivalent of mad cow disease.
The new study, led by The Scripps Research Institute (TSRI) Professor Corinne Lasmezas and performed in collaboration with TSRI Professor Emeritus Charles Weissmann and Director of Lead Identification Peter Hodder, used an innovative high-throughput screening technique to uncover compounds that decrease the amount of the normal form of the prion protein (PrP, which becomes distorted by the disease) at the cell surface.
The scientists found two compounds that reduced PrP on cell surfaces by approximately 70 percent in the screening and follow up tests.
The two compounds are already marketed as the drugs tacrolimus and astemizole.
Tacrolimus is an immune suppressant widely used in organ transplantation. Tacrolimus could prove problematic as an anti-prion drug, however, because of issues including possible neurotoxicity.
However, astemizole is an antihistamine that has potential for use as an anti-prion drug. Astemizole not only crosses the blood-brain barrier, but works effectively at a relatively low concentration.
Lasmezas noted that astemizole appears to stimulate autophagy, the process by which cells eliminate unwanted components. "Autophagy is involved in several protein misfolding neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases," she said. "So future studies on the mode of action of astemizole may uncover potentially new therapeutic targets for prion diseases and similar disorders."
The study will be published in the journal Proceedings of the National Academy of Sciences. (ANI)
Read More: Airforce Academy | U.g.c.works | L.w.works(guntur) | K.c.works | Agricultural Research Centre | Officer's Training Academy | Central Leather Research Insti | Indian Research Po | Haringhat River Research Insti | Rubber Research Station | Assam Engg. Institute | Morarji Desai National Institute of Yoga | National Academy of Direct Taxes | Human Resource Management | National Institute of Homeopathy | Gandhigram Rural Institute | National Dairy Research Institute | Central Institute of Indian Language | National Institute of Virology | Mahavir Cancer Sansthan and Research Centre Patna | Alzheimer
SAHARANPUR LOCALS COMPLAIN OF LONG QUEUES FOR NECESSITIES
July 28, 2014 at 8:46 PM
TMC DOES NOTHING TO PREVENT VIOLENCE BIMAN BOSE
July 28, 2014 at 8:45 PM
" SHAKTISINH GOHIL QUESTIONS BJP FUNDING OF POLL CAMPAIGN "
July 28, 2014 at 8:45 PM
MUZAFFARNAGAR MP BLAMES SP FOR SAHARANPUR RIOTS
July 28, 2014 at 8:44 PM
Calcutta HC directs CID to probe Tapas Pal hate speech and submit report
July 28, 2014 at 8:18 PM
Kashmir decks up for Eid-ul-Fitr celebrations
July 28, 2014 at 7:54 PM